Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Muhammad Abdullah Yousaf"'
Autor:
Hafiz Muhammad Fazeel, Ahmed Ibrahim, Ceren Durer, Rida Riaz, Seren Durer, Mustafa Nadeem Malik, Muhammad Abdullah Yousaf, Shehroz Aslam, Muhammad Abu Zar
Publikováno v:
Cureus
Problem-based learning is a learner-centered teaching method, which uses real-world scenarios to promote student learning of concepts and principles. The aim of our study is to analyze the consequence of increased problem difficulty on team-based lea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c449e39d2bf385af5a92331fdc2ef861
https://pubmed.ncbi.nlm.nih.gov/31392105
https://pubmed.ncbi.nlm.nih.gov/31392105
Publikováno v:
Cureus
Biliary cysts are rare cystic dilatations of the biliary tree. Biliary cysts are positively associated with several significant complications, amongst them, cholangiocarcinoma befalls the most dreadful one. The elevated incidence is 20-30% in the unr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d777730fe38cc954263e99b8d61bcdc3
https://doi.org/10.7759/cureus.4532
https://doi.org/10.7759/cureus.4532
Autor:
Syed Maaz Abdullah, Syeda Sabeeka Batool, Syeda Fatima Hassan, Muhammad Abdullah Yousaf, Tariq Iqtidar Sadiq Syed, Faiz Anwer, Aqsa Ashraf, Zunairah Shah, Mustafa Nadeem Malik, Muhaddis Ejaz Ahmad, Maryam Sadiq, Arafat Ali Farooqui, Nisma Javed, Marium Ghani, Arshia Akbar, Hafiz Muhammad Fazeel
Publikováno v:
Blood. 134:5597-5597
Introduction Multiple Myeloma (MM) is a plasma cell dyscrasia characterized by neoplastic proliferation of plasma cells. Despite the recent advances in disease management, it still contributes to significant morbidity and mortality, thus highlighting
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2ccfa373594eaf0f06dc93c51cc9087c
https://doi.org/10.1182/blood-2019-131849
https://doi.org/10.1182/blood-2019-131849
Autor:
Muhammad Qudrat Ullah, Muhammad Yasir Anwar, Muhammad Abdullah Yousaf, Mustafa Nadeem Malik, Maaz Ahmed Yusufi, Abdul Rafae, Faiz Anwer, Zunairah Shah, Muhaddis Ejaz Ahmad, Asim Tameez Ud Din, Ahmed Ibrahim
Publikováno v:
Blood. 134:5579-5579
Introduction FDA (Food and Drug Administration) fast track program facilitates the development and accelerated review of new drugs aimed at treating life-threatening conditions and having the potential to address unmet medical needs. FDA fast track d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2003d1b401e3bae7ac56b1e3a148c275
https://doi.org/10.1182/blood-2019-123296
https://doi.org/10.1182/blood-2019-123296
Autor:
Marium Ghani, Muhammad Abdullah Yousaf, Sravanthi Kotapati, Mustafa Nadeem Malik, Arshia Akbar, Faiz Anwer, Aqsa Ashraf, Syeda Sabeeka Batool, Muhaddis Ejaz Ahmad, Owais ur Rehman, Aisha Akhtar, Arafat Ali Farooqui, Hafiz Muhammad Fazeel, Zunairah Shah, Maryam Sadiq
Publikováno v:
Blood. 134:5567-5567
Introduction Bispecific T-cell engager (BiTE) antibodies represent a novel therapeutic option for patients with multiple myeloma (MM). BiTE antibodies lack Fc region, and have variable domain only, they can simultaneously bind to two different epitop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b1ce3c0d6e00564c6753e3dd8e34b47f
https://doi.org/10.1182/blood-2019-129652
https://doi.org/10.1182/blood-2019-129652
Autor:
Maimoona Khan, Muhammad Saad Farooqi, Arafat Ali Farooqui, Tariq Iqtidar Sadiq Syed, Muhaddis Ejaz Ahmad, Muhammad Abdullah Yousaf, Rida Ul Jannat, Asma Waheed, Madeeha Shafqat, Sravanthi Kotapati, Faiz Anwer, Syed Maaz Abdullah, Ali Younas Khan, Irbaz Bin Riaz
Publikováno v:
Blood. 134:5588-5588
Background: Carfilzomib (Car), a second-generation proteasome inhibitor (PI), has been approved by the US Food and Drug Administration (FDA) as therapy for relapsed and /or refractory multiple myeloma (RRMM), either as a single agent or in combinatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9f7f4c9ec2022402ab6452ae80675d04
https://doi.org/10.1182/blood-2019-128833
https://doi.org/10.1182/blood-2019-128833
Autor:
Hamza Hassan, Ahmad Iftikhar, Midhat Lakhani, Muhammad Abdullah Yousaf, Muhaddis Ejaz Ahmad, Adeela Mushtaq, Irbaz Bin Riaz, Faiz Anwer, Seemal Iftikhar, M. Hasib Sidiqi, Razwana Khanam, Aneeqa Zafar, Maaz Ahmed Yusufi
Publikováno v:
Blood. 134:5556-5556
Introduction Amyloidosis is a rare disease and there are currently no FDA approved therapies for AL amyloidosis. Most of the therapeutic and disease data come from expert guidelines, consensus and retrospective review papers. There is a paucity of da
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8175458d9ba4de2d6b13f24271d0f073
https://doi.org/10.1182/blood-2019-125148
https://doi.org/10.1182/blood-2019-125148
Autor:
Muhammad Abdullah Yousaf, Saif Ur Rehman, Tariq Iqtidar Sadiq Syed, Muhammad Salman Faisal, Maimoona Khan, Awais Ijaz, Muhaddis Ejaz Ahmad, Asma Waheed, Sravanthi Kotapati, Syed Maaz Abdullah, Syeda Sabeeka Batool, Khadija Zia Zaidi, Sikander Abdullah, Maaz Ahmed Yusufi, Faiz Anwer
Publikováno v:
Blood. 134:5589-5589
Introduction: About 60% newly diagnosed multiple myeloma (NDMM) cases are above age of 60 years. The paucity of studies exclusively targeting management of frail patients has led to persistence of therapeutic uncertainties. With data on more than ten
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9051db837f3545df167bce7baf2d70e6
https://doi.org/10.1182/blood-2019-128892
https://doi.org/10.1182/blood-2019-128892
Autor:
Asma Waheed, Syed Maaz Abdullah, Faiz Anwer, Tariq Iqtidar Sadiq Syed, Maimoona Khan, Muhammad Abdullah Yousaf, Muhaddis Ejaz Ahmad, Abdul Rafae, Fazeel Qamar, Mustafa Nadeem Malik, Ahmed Ibrahim
Publikováno v:
Blood. 134:5561-5561
Introduction: Melphalan causes cross linkage between DNA, causes cytotoxicity in both dividing and non-dividing tumor cells. Our objective is to analyze and summarize the published literature for the efficacy of melphalan based regimen used for the t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ab413608f4f5f4db66df2bc3511ec8c2
https://doi.org/10.1182/blood-2019-127192
https://doi.org/10.1182/blood-2019-127192
Autor:
Fazeel Qamar, Ahmed Ibrahim, Tariq Iqtidar Sadiq Syed, Syed Maaz Abdullah, Zunairah Shah, Muhammad Abdullah Yousaf, Muhaddis Ejaz Ahmad, Mustafa Nadeem Malik, Faiz Anwer, Abdul Rafae
Publikováno v:
Blood. 134:5584-5584
Introduction: Lenalidomide (L), a commonly used drug for the treatment of Multiple Myeloma, but currently it is not being not used as front line agent for the treatment of AL amyloidosis. It works through various mechanism, can cause direct toxicity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::871be74a423760aed54f5bb5e780175e
https://doi.org/10.1182/blood-2019-127236
https://doi.org/10.1182/blood-2019-127236